BUCHAREST, Romania--(BUSINESS WIRE)--
A&D PHARMA HOLDINGS N.V.
DUTCH ENTERPRISE CHAMBER REJECTS APPLICATION FOR INTERLOCUTORY MEASURES AGAINST THE DELISTING OF GDRs
A&D Pharma Holdings N.V. (the Company or A&D Pharma), the Dutch holding company that owns the largest integrated pharmaceutical wholesale, sales and marketing services and retail business in Romania, announces that it has today received an interlocutory judgement from the Enterprise Chamber of the Court of Appeal of Amsterdam.
As announced by the Company on 14 January 2011, a group of GDR holders opposing the proposed cancellation of the Company's listing on the Official List of the Financial Services Authority and admission to trading on the London Stock Exchange (Delisting) applied to the Enterprise Chamber for certain interlocutory measures. The Enterprise Chamber has rejected in full the request for interlocutory measures.
As a result of the judgment of the Enterprise Chamber, the Extraordinary General Meeting of Shareholders (EGM) convened to vote on the Delisting will proceed today as planned at 14.30 CET at the Hilton Hotel, Amsterdam Airport Schiphol, Schipholboulevard 701, 1118 BN Schiphol Centrum in The Netherlands.
The results of the EGM will be announced by the Company shortly after the EGM later today
For further information, please visit www.adpharma.com or for enquiries contact:
|
Advisers to the Company Montrose Partners LLP Aeneas Mackay/Matthew Clarke +44 207 484 0905 |
ABOUT A&D PHARMA
A&D Pharma Holdings N.V. is the Dutch holding company of A&D Pharma Holdings S.R.L., the leading pharmaceutical wholesale, marketing and sales services and retail business in Romania. Founded in 1994, the Group owns Romania’s leading pharmaceutical wholesale, sales and marketing services for CHC and Rx products network “Mediplus”, and Romania’s largest national branded chain of pharmacies “Sensiblu”.
A&D Pharma’s shares have been traded in the form of GDRs on the regulated market of the London Stock Exchange since October 2006 under the symbol 'ADPH'.
This release is not an offer for sale of the GDRs of A&D Pharma, or any other of its securities, in the United States or in any jurisdiction where any offer, sale or solicitation in respect of such securities is not permitted. Securities may not be offered or sold in the United States absent registration or an exemption from registration under the US Securities Act of 1933, as amended, or in any jurisdiction where such offer or sale is not permitted.
Certain statements made in this release are forward looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause actual events or results to differ materially from any expected future events or results referred to in these forward looking statements.
This release should not be construed as the giving of advice or the making of a recommendation and should not be relied on as a basis for any decision or action. In particular, actual results and developments may be materially different from any forecast, opinion or expectation expressed in this presentation and the past performance of the price of securities must not be relied upon as a guide to their future performance.